Top compounds associated with response to KRT81


Feature Type Standardized
Nominal ANOVA
mRNA NVP-231 CTRPv2 pan-cancer AAC -0.058 0.07
mRNA masitinib GDSC1000 pan-cancer AAC -0.061 0.07
mRNA lapatinib UHNBreast pan-cancer AAC 0.51 0.07
mRNA triazolothiadiazine CTRPv2 pan-cancer AAC -0.053 0.07
mRNA JW-7-24-1 GDSC1000 pan-cancer AAC -0.055 0.08
mRNA Bortezomib CTRPv2 pan-cancer AAC -0.061 0.08
mRNA Erlotinib CTRPv2 pan-cancer AAC 0.061 0.08
mRNA SN-38 CTRPv2 pan-cancer AAC -0.064 0.08
mRNA decitabine:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.055 0.08
mRNA selumetinib:BRD-A02303741 (4:1 mol/mol) CTRPv2 pan-cancer AAC 0.061 0.08
Download CSV